Bortezomib, Ifosfamide, Carboplatin, and Etoposide in a Patient with HIV-Negative Relapsed Plasmablastic Lymphoma
Plasmablastic lymphoma (PBL) is a rare subtype of diffuse large B cell lymphoma (DLBCL), often associated with HIV infection. We present a case of a 53-year-old HIV-negative man with untreated hepatitis C viral infection who presented with abdominal pain and lymphadenopathy. Lymph node and bone marr...
Saved in:
Main Authors: | Mehmet Akce, Elaine Chang, Mohammad Haeri, Mike Perez, Christie J. Finch, Mark M. Udden, Martha P. Mims |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2016/3598547 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic Dilemma
by: Alaina J. Kessler, et al.
Published: (2019-01-01) -
Plasmablastic Lymphoma: A Systematic Review
by: Jorge J. Castillo, et al.
Published: (2011-01-01) -
Tibial Plasmablastic Lymphoma in a HIV-Negative Child: A Novel Extraoral Localisation
by: Ali Mala, et al.
Published: (2022-01-01) -
J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan
by: Eisaku Miyauchi, MD, PhD, et al.
Published: (2025-03-01) -
The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
by: Eko A. Pangarsa, et al.
Published: (2021-01-01)